Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections
NCT04395911 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2021-08-05
Summary
Selective Cytopheretic Device (SCD) treatments will improve survival in patients testing positive for COVID-19 infection diagnosed with Acute Kidney Injury (AKI) or ARDS.
Conditions
Interventions
- DEVICE
-
SCD
cytopheretic device
Sponsors & Collaborators
-
SeaStar Medical
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-10
- Primary Completion
- 2021-07-05
- Completion
- 2021-07-21
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Safety and Efficacy of Extracorporeal Cytokine Hemoadsorption in Septic Shock in Critically Ill Cirrhotics
NCT03866083 ·Status: UNKNOWN ·Phase: NA
-
Citrate Versus Heparin Anticoagulation: Effect on Molecules Clearances
NCT01839578 ·Status: UNKNOWN ·Phase: NA
-
ECMOsorb Trial - Impact of a VA-ECMO in Combination With CytoSorb in Critically Ill Patients With Cardiogenic Shock
NCT05027529 ·Status: COMPLETED ·Phase: NA
-
Comparing Cytokines, Toxins Adsorbing oXiris Filter to ST150 Filter During CRRT in Patients With Septic Shock
NCT02600312 ·Status: COMPLETED ·Phase: NA
-
Clearance of Vasoactive Metabolites With Blood Purification
NCT06109142 ·Status: RECRUITING
-
Efficacy Study of CytoSorb Hemoperfusion Device on IL-6 Removal in ARDS/ALI Patients With Sepsis
NCT00559130 ·Status: COMPLETED ·Phase: NA
-
HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections: a Multicenter Pilot Study
NCT03744741 ·Status: COMPLETED
-
Prospective Study to Characterize Host-pathogen Related Factors in Hospitalized and ED Patients With LRTI and/or Sepsis
NCT02025699 ·Status: COMPLETED
-
Rapid Recognition of Corticosteroid Resistant or Sensitive Sepsis
NCT04280497 ·Status: RECRUITING ·Phase: NA
-
RRT With a Cytokine Absorption Filter (oXiris ®) in Patients With Septic Shock
NCT04952714 ·Status: COMPLETED
-
Immunothrombosis With Septic Shock Undergoing Renal Replacement Therapy With the OXIRIS Membrane
NCT06440317 ·Status: RECRUITING
-
Effect of Dynamic Arterial Elastance and Assisted Fluid Management Software Guided Resuscitation in Septic Shock: Pilot Study
NCT06937918 ·Status: RECRUITING ·Phase: NA
-
Effect of Sepsis Adsorption Column on Syndecan-1 and Mortality
NCT07033910 ·Status: COMPLETED
-
Angiotensin in Septic Kidney Injury Trial
NCT00711789 ·Status: UNKNOWN ·Phase: PHASE2
-
Metrology to Enable Rapid and Accurate Clinical Measurements in Acute Management of Sepsis
NCT05338359 ·Status: UNKNOWN
-
MR-Evaluation of Renal Function In Septic Patients
NCT02765191 ·Status: COMPLETED ·Phase: NA
-
Microcirculatory Oxygen Uptake in Sepsis
NCT02430142 ·Status: COMPLETED
-
Effects of Endotoxin Absorption and Cytokine Removal Hemofilter on Severe Septic Shock
NCT03974386 ·Status: COMPLETED ·Phase: NA
-
Evaluating a CytoSorb Score in Septic Shock
NCT03977688 ·Status: COMPLETED
-
Cefiderocol PK in Patients on ECMO
NCT04995835 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy & Safety of Resatorvid in Adults With Severe Sepsis
NCT00143611 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Plasma Exchange Adsorption Diafiltration
NCT03589378 ·Status: UNKNOWN ·Phase: NA
-
Cytokine Adsorption in Severe, Refractory Septic Shock
NCT04910893 ·Status: COMPLETED ·Phase: NA
-
Lactate Kinetics in Septic Shock
NCT05349370 ·Status: RECRUITING ·Phase: NA
-
Peripheral Artery Disease and Sepsis Outcomes
NCT03372330 ·Status: UNKNOWN